{
  "id": "adv_mhgap#risk_safety_c7cce0c5",
  "content": "in delivering mental health care, resistance due\nresources than usual care models (although there is\nto feeling overburdened, stigma or medical\nevidence to suggest it may provide good economic\nhierarchies among providers.\nvalue). The human resources required for CC vary\nwidely based on how the components of the model\nare adapted for implementation in a given setting.\n27\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\n3.3 Child and adolescent mental disorders (CAMH)\nCAMH1. What is the effectiveness and safety of pharmacological\ninterventions for children with a diagnosis of attention\ndeficit hyperactivity disorder (ADHD)?\nRecommendation (update): For children 6 years old and above and adolescents who have an attention\ndeficit hyperactivity disorder (ADHD) diagnosis, methylphenidate may be\nconsidered, provided that:\ny ADHD symptoms are still causing persistent significant impairment in at\nleast one domain of functioning (education, interpersonal relationships,\noccupation), after the implementation of environmental modifications in\nschools, at home or in other relevant settings;\ny a careful assessment of the child/adolescent has been conducted;\ny the child/adolescent and the caregivers, as appropriate, have\nbeen informed about ADHD treatment options and supported\nin decision-making;\ny methylphenidate prescription is made by, or in consultation with,",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "relationships",
      "risk_safety",
      "screening_cues",
      "management",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General â€” Risk Safety in delivering mental health care, resistance due\nresources than usual care models (although there is\nto feeling overburdened, stigma or medical\nevidence to suggest it may provide good economic\nhierarchies among providers.\nvalue). The human resources required for CC vary\nwidely based on how the components of the model\nare adapted for implementation in a given setting.\n27\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\n3.3 Child and adolescent mental disorders (CAMH)\nCAMH1. What is the effectiveness and safety of pharmacological\ninterventions for children with a diagnosis of attention\ndeficit hyperactivity disorder (ADHD)?\nRecommendation (update): For children 6 years old and above and adolescents who have an attention\ndeficit hyperactivity disorder (ADHD) diagnosis, methylphenidate may be\nconsidered, provided that:\ny ADHD symptoms are still causing persistent significant impairment in at\nleast one domain of functioning (education, interpersonal relationships,\noccupation), after the implementation of environmental modifications in\nschools, at home or in other relevant settings;\ny a careful assessment of the child/adolescent has been conducted;\ny the child/adolescent and the caregivers, as appropriate, have\nbeen informed about ADHD treatment options and supported\nin decision-making;\ny methylphenidate prescription is made by, or in consultation with, In delivering mental health care, resistance due\nresources than usual care models (although there is\nto feeling overburdened, stigma or medical\nevidence to suggest it may provide good economic\nhierarchies among providers..."
}